Regeneron Pharmaceuticals Inc (REGN)
1071.62
+7.47
(+0.70%)
USD |
NASDAQ |
Jun 25, 16:00
1072.13
+0.51
(+0.05%)
After-Hours: 20:00
Regeneron Pharmaceuticals EPS Diluted (Annual): 34.77 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 34.77 |
December 31, 2022 | 38.22 |
December 31, 2021 | 71.97 |
December 31, 2020 | 30.52 |
December 31, 2019 | 18.46 |
December 31, 2018 | 21.29 |
December 31, 2017 | 10.34 |
December 31, 2016 | 7.70 |
December 31, 2015 | 5.52 |
December 31, 2014 | 2.98 |
December 31, 2013 | 3.72 |
December 31, 2012 | 6.75 |
December 31, 2011 | -2.45 |
December 31, 2010 | -1.26 |
December 31, 2009 | -0.85 |
December 31, 2008 | -1.00 |
December 31, 2007 | -1.59 |
Date | Value |
---|---|
December 31, 2006 | -1.77 |
December 31, 2005 | -1.71 |
December 31, 2004 | 0.74 |
December 31, 2003 | -2.13 |
December 31, 2002 | -2.83 |
December 31, 2001 | -1.81 |
December 31, 2000 | -0.66 |
December 31, 1999 | -0.74 |
December 31, 1998 | -0.28 |
December 31, 1997 | -0.40 |
December 31, 1996 | -1.33 |
December 31, 1995 | -1.19 |
December 31, 1994 | -1.62 |
December 31, 1993 | -2.41 |
December 31, 1992 | -1.24 |
December 31, 1991 | -0.29 |
December 31, 1990 | -0.63 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
18.46
Minimum
2019
71.97
Maximum
2021
38.79
Average
34.77
Median
2023
EPS Diluted (Annual) Benchmarks
Amgen Inc | 12.49 |
Vertex Pharmaceuticals Inc | 13.89 |
Eli Lilly and Co | 5.80 |
Pfizer Inc | 0.37 |
Moderna Inc | -12.33 |